MoneyWorks4Me

Ajanta Pharma reports 26% rise in Q2 consolidated net profit

26 Oct 2016 Evaluate

Ajanta Pharma has reported results for second quarter ended September 30, 2016.  

The company has reported 27.42% rise in its net profit at Rs 120.95 crore for the quarter under review as compared to Rs 94.92 crore for the same quarter in the previous year. Total income of the company increased by 16.07% at Rs 484.42 crore for the quarter under review as compared Rs 417.36 crore for the corresponding quarter previous year.   

On the consolidated basis, the company has reported 26.31% rise in its net profit after taxes, minority interest and share of profit of associates at Rs 130.66 crore for the quarter ended September 30, 2016 as compared to Rs 103.44 crore for the same quarter in the previous year. Total Income of the company has increased by 16.66% to Rs 522.48 crore for quarter under review from Rs 447.86 crore for the quarter ended September 30, 2015.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..